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Abstract	
Background	People	who	opt	to	participate	in	scientific	studies	tend	to	be	healthier,	wealthier,	and	more	educated	than	the	broader	population.	While	selection	bias	does	not	always	pose	a	problem	for	analysing	the	relationships	between	exposures	and	diseases	or	other	outcomes,	it	can	lead	to	biased	effect	size	estimates.	Biased	estimates	may	weaken	the	utility	of	genetic	findings	because	the	goal	is	often	to	make	inferences	in	a	new	sample	(such	as	in	polygenic	risk	score	analysis).		
Methods		We	used	data	from	UK	Biobank,	Generation	Scotland,	and	Partners	Biobank	and	conducted	phenotypic	and	genome-wide	association	analyses	on	two	phenotypes	that	reflected	mental	health	data	availability:	(1)	whether	participants	were	contactable	by	email	for	follow-up	and	(2)	whether	participants	responded	to	follow-up	surveys	of	mental	health.			
Results	In	UK	Biobank,	we	identified	nine	genetic	loci	associated	(P	<	5	×	10-8)	with	email	contact	and	25	loci	associated	with	mental	health	survey	completion.	Both	phenotypes	were	positively	genetically	correlated	with	higher	educational	attainment	and	better	health	and	negatively	genetically	correlated	with	psychological	distress	and	schizophrenia.	One	SNP	association	replicated	along	with	the	overall	direction	of	effect	of	all	association	results.		
Conclusions	Recontact	availability	and	follow-up	participation	can	act	as	further	genetic	filters	for	data	on	mental	health	phenotypes.			
Keywords/MeSH:	selection	bias,	cohort	studies,	mental	health,	follow-up	studies,	genome-wide	association	study,	UK	Biobank,	Generation	Scotland,	Partners	Biobank		
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Key	Messages		
• Large	cohort	studies	show	a	“healthy	volunteer	bias”	and	this	type	of	selection	bias	has	a	polygenic	basis.	
• Participants	who	take	part	in	follow-up	studies	of	mental	health	differ	from	participants	who	do	not,	and	tend	to	be	healthier,	better	education,	and	have	a	family	history	of	dementia	and/or	depression.	
• Genetic	factors	that	positively	associate	with	follow-up	survey	participation	are	positively	related	to	cognitive	function	and	psychological	well-being	and	negatively	related	to	psychiatric	disorders.			
Introduction	
Selection	bias	in	epidemiological	and	cohort	studies	occurs	when	characteristics	of	individuals	that	influence	their	likelihood	of	becoming	or	remaining	as	study	participants	are	also	related	to	exposure	to	risk	factors	or	to	outcomes	of	interest	1.	Selection	bias	can	be	introduced	at	many	stages	of	a	study,	including	at	recruitment,	at	follow	up,	during	record	linkage,	or	in	non-response	to	questionnaires	or	tasks	and	has	the	potential	to	lead	to	misestimates	of	phenotypic	and	genetic	associations	2.	For	example,	a	longitudinal	study	of	psychiatric	traits	identified	several	characteristics	related	to	loss-to-follow-up	including	age;	education;	ancestry;	geographic	location;	and	the	presence,	severity,	and	comorbidity	of	anxiety	and	depression	3.	There	are	several	methods	for	handling	selection	bias	if	and	when	it	needs	to	be	taken	into	consideration.	When	all	variables	that	influence	selection	and	attrition	are	known,	then	bias	can	potentially	be	reduced	or	eliminated	by	conditioning	on	known	variables	or	including	
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them	as	predictors	4.	In	longitudinal	studies,	techniques	such	as	inverse	probability	weighting,	where	observations	that	are	similar	to	those	that	were	lost	to	follow-up	contribute	proportionally	more	to	the	analysis,	can	be	used	to	correct	for	selection	bias	
5.	Given	the	importance	of	selection	bias	on	inference,	it	is	crucial	to	fully	characerise	it	in	any	given	study	population.			 Initial	ascertainment	and	recontact	have	been	demonstrated	to	have	a	genetic	basis.	For	example,	individuals	who	had	a	high	genetic	risk	of	schizophrenia	(calculated	from	polygenic	risk	scores)	were	less	likely	to	complete	follow-up	questionnaires	or	attend	additional	data	collection	sessions	6.	and	genetic	propensity	for	other	traits	have	similar	effects7.		Participation	in	large	cohort	studies	is	already	known	to	have	a	“healthy	volunteer”	effect	8,	so	we	sought	to	characterise	the	phenotypic	and	genetic	correlates	of	participation	in	follow-up	studies	focused	on	assessing	mental	health	traits.	To	this	end,	we	analysed	recontact	and	participation	in	three	studies:	the	Mental	Health	Questionnaire	(MHQ)	online	follow-up	in	UK	Biobank	9	(N	=	371	417	-	373	478),	the	Stratifying	Resilience	and	Depression	Longitudinally	(STRADL)	study	in	Generation	Scotland	10	(N	=	19	994),	and	the	Partners	Biobank	11	(N	=	15	925).	We	conducted	phenotypic	and	genome-wide	association	analyses	in	UK	Biobank	to	determine	how	participants	who	completed	the	MHQ	differed	from	the	rest	of	the	sample.	We	also	analysed	factors	related	to	whether	UK	Biobank	participants	were	contactable	by	email,	as	email	invitations	were	the	primary	method	of	recruitment	into	the	MHQ	follow-up.	We	used	participation	in	the	STRADL	questionnaire	follow-up	in	Generation	Scotland	and	a	health	information	survey	follow-up	questionnaire	in	the	Partners	Biobank	as	replication	data	sets	for	genetic	findings.			 Conducting	genetic	analyses	of	selection	bias	and	loss-to-follow-up	can	complement	and	add	to	existing	knowledge	gained	by	comparing	biobank	cohorts	to	
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national	statistics	and	published	disease	incidences	and	by	comparing	follow-up	responders	and	non-responders	on	key	characteristics.	A	participant’s	decision	to	continue	to	engage	in	a	research	study	is	likely	to	be	multifactorial.	Genetic	analyses	are	a	pragmatic	first	step	in	indicating	what	the	many	contributing	factors	are	since	genome-wide	association	summary	statistics	can	be	efficiently	compared	to	those	from	hundreds	of	other	studies.	Genetic	analyses	can	be	revealing	in	other	ways.		First,	genetic	and	environmental	factors	may	have	different	magnitudes	or	directions	of	association	with	follow-up	participation.	Thus,	genetic	studies	of	follow-up	samples	may	differ	in	the	degree	to	which	they	are	susceptible	to	selection	bias	compared	to	phenotypic	studies.	Second,	a	genetic	study	makes	it	possible	to	evaluate	selection	bias	from	traits	that	are	only	measured	in	a	follow-up	sample.	For	example,	the	Mental	Health	Questionnaire	in	UK	Biobank	includes	evaluations	of	depression,	anxiety,	addiction,	and	trauma	that	were	not	measured	at	baseline,	so	it	is	not	possible	to	directly	compare	responders	and	non-responders	on	these	traits.	Comparisons	between	responders	and	non-responders	can	even	be	made	for	traits	that	are	rare	or	not	even	measured	in	the	biobank.	Genetic	analyses	can	be	correlated	with	external	genome-wide	summary	statistics	to	elucidate	the	role	of	liability	to	disorders	that	are	rare	in	most	biobank	samples,	such	as	anorexia	and	schizophrenia.	Finally,	genetic	summary	statistics	for	follow-up	response	in	a	large	sample	in	UK	Biobank	can	become	the	basis	for	the	analysis	of	selection	bias	in	other	genetic	cohorts.	
Methods	
Samples	UK	Biobank	(UKB)		is	a	population-based	study	of	health	in	middle-aged	and	older	individuals	(N	=	502	616).	Eligible	participants	were	aged	40	to	69	and	recruited	from	22	assessment	centres	in	the	United	Kingdom.	UK	Biobank	received	ethical	approval	
 6 
 
from	the	Research	Ethics	Committee	(reference	11/NW/0382).	The	present	study	was	conducted	under	UK	Biobank	application	4844.	Generation	Scotland:	Scottish	Family	Health	Study	(GS:SFHS)	is	a	family-based	cohort	(N	=	24	091)	recruited	through	general	practitioners	in	Scotland	12,	13.	Eligible	participants	were	aged	18	years	or	older	who	were	able	to	recruit	one	or	more	family	members	into	the	study.	GS:SFHS	received	ethical	approval	from	the	Tayside	Research	Ethics	Committee	(reference	05/S1401/89).	Partners	Biobank:	The	Partners	Biobank	is	a	hospital-based	cohort	study	from	the	Partners	HealthCare	hospitals	with	electronic	medical	records	and	genetic	data	supplemented	with	electronic	health	and	lifestyle	surveys	11.	Recruitment	started	in	2010	(N=78	726	in	2018)	and	is	ongoing	at	participating	across	several	clinics	including	Brigham	and	Women’s	Hospital	and	Massachusetts	General	Hospital.	All	participants	provided	consent	upon	enrolment.	The	current	analysis	was	restricted	to	adults	≥18	years	of	age	and	of	European	ancestry14	with	high-quality	genotyping	data	at	the	time	of	analysis.	
Recontact	and	participation	measures	During	recruitment	and	baseline	assessment	(2006-2010),	UKB	participants	were	given	the	option	of	supplying	an	email	address	for	receiving	newsletters	and	invitations	for	online	follow-up	assessments.	Of	the	317	785	participants	who	supplied	an	email	address,	294	738	provided	a	usable	one	while	the	remaining	23	047	either	provided	a	syntactically	incorrect	or	non-existent	email	address	or	asked	that	their	email	address	be	withdrawn.	An	email	address	was	not	provided	by	184	831	UKB	participants	during	baseline	assessment.	While	this	variable	is	called	“email	access”	in	the	UK	Biobank	documentation	(field	20005),	we	refer	to	this	phenotype	as	“email	contact”.	Although	additional	UK	Biobank	participants	have	subsequently	provided	an	email	address	for	
 7 
 
recontact	,	here	we	analyse	the	baseline	availability	of	email	contact	so	that	it	can	be	related	to	other	baseline	factors	that	were	captured	contemporaneously.		 Starting	in	2016,	UKB	participants	who	had	provided	email	contact	were	sent	an	invitation	to	an	online	Mental	Health	Questionnaire	(MHQ)	entitled	"thoughts	and	feelings"	9.	Participants	who	had	not	started	the	questionnaire	or	had	only	partially	completed	it	were	sent	reminder	emails	after	two	weeks	and	again	after	four	months.	Participants	also	received	information	about	the	MHQ	in	a	postal	newsletter	with	instructions	on	how	to	participate.	From	data	supplied	by	UK	Biobank	on	12	June	2018,	157	396	participants	had	completed	the	MHQ.	Responses	to	the	MHQ	were	submitted	between	July	2016	and	July	2017.	Mean	time	between	baseline	assessment	and	MHQ	follow-up	was	7.5	years	(range	5.9–11.2	years).	We	refer	to	this	phenotype	as	“MHQ	data”.			 In	2015,	GS:SFHS	participants	were	sent	a	questionnaire	package	by	post	as	part	of	the	Stratifying	Resilience	and	Depression	Longitudinally	(STRADL)	project	with	the	aim	of	studying	psychological	resilience	10.	Participants	were	eligible	for	follow	up	if	they	had	consented	to	recontact	and	if	they	had	a	Community	Health	Index	(CHI)	number.	Of	the	21	525	eligible	participants,	9618	responded	to	the	questionnaire,	from	which	we	coded	a	“STRADL	data”	phenotype.			 In	the	Partners	Biobank,	following	enrolment,	participants	were	invited	to	complete	the	Partners	Biobank	Health	Information	Survey,	an	optional	online	lifestyle,	environment,	and	family	history	survey14.	Of	the	15	925	participants	of	European	ancestry	with	genetic	data	at	the	time	of	analysis,	6639	responded	to	the	questionnaire.		
Phenotype	analysis	
 8 
 
Demographic	and	health	differences	between	responders	and	non-responders	to	the	STRADL	survey	have	been	analysed	previously	and	found	that,	among	other	differences,	participants	who	were	women,	non-smokers,	or	who	had	low	levels	of	psychological	distress	were	more	likely	to	respond.	We	thus	first	conducted	a	similar	analysis	in	UK	Biobank.	We	ran	logistic	regressions	for	email	contact	and	MHQ	data	using	R	3.5.0	15.	We	examined	associations	with	age	at	initial	assessment,	sex,	geographic	region,	educational	qualification,	smoking,	alcohol	consumption,	number	of	diagnoses	in	linked	electronic	health	records,	and	family	history	of	dementia	and	depression	(see	Supplementary	Information	for	regression	input	coding).			
Genome-wide	association,	LD	Score	analysis,	and	replication	analysis	We	conducted	genome-wide	association	studies	(GWAS)	on	the	UKB	email	contact	and	MHQ	data	phenotypes	and	conducted	gene-based	association	and	gene-set	analyses	(see	Supplementary	Information).	We	calculated	a	genomic	control	factor	(lGC)16	for	each	set	of	GWAS	results,	which	measures	the	inflation	in	test	statistics	above	what	would	be	expected	by	chance.	Inflation	in	test	statistics	can	caused	both	by	a	large	number	of	genetic	variants	having	an	association	with	each	trait	(polygenicity)	or	by	confounding	factors,	including	population	stratification	and	relatedness	within	the	sample.	We	used	LD	score	regression	17	to	distinguish	polygenicity	from	confounding.	LD	score	regression	exploits	the	increase	in	association	test	statistics	for	genetic	loci	that	are	closely	linked	in	the	region	surrounding	each	causal	genetic	variant	(indicating	polygenicity)	from	confounding,	which	is	expected	to	inflate	test	statistics	evenly	across	the	whole	genome.	The	intercept	from	an	LD	score	regression	quantifies	the	test	statistic	inflation	from	confounding	factors,	where	an	intercept	estimate	close	to	1.0	indicates	no	confounding.	We	also	used	LD	Score	regression	to	estimate	the	proportion	
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of	variance	in	these	traits	attributable	to	common	genetic	variants	(also	referred	to	as	SNP	heritability)	and	calculated	genetic	correlations	with	235	traits	using	LD	Hub.	We	used	False	Discovery	Rate	to	correct	for	multiple	testing.	To	test	for	possible	effects	of	mortality	on	loss-to-follow-up,	we	used	the	death	register	to	identify	participants	whose	death	occurred	before	the	MHQ	assessment	(N	=	10	623).	We	then	ran	a	GWAS	on	MHQ	data	with	these	participants	removed.	In	the	replication	data	sets	(Generation	Scotland	and	Partners	Biobank)	we	first	tested	for	replication	of	independent	SNPs	(r2	=	0.1,	250kb	window)	after	Bonferroni	correction.	We	calculated	the	expected	power	of	replication	using	the	GAS	power	calculator18.	Following	that,	we	tested	for	replication	of	direction	of	effect	by	performing	a	binomial	test	for	the	number	of	SNPs	with	the	same	direction	of	effect	between	the	UK	Biobank	and	Partners	association	results.	We	also	calculated	LD	Score	genetic	correlations17	between	the	UK	Biobank	and	Generation	Scotland	summary	statistics	to	estimate	genome-wide	similarity	in	phenotypes	between	these	studies.			
Results	
Phenotypic	associations	of	email	contact	and	mental	health	follow-up	(MHQ)	data	
in	UK	Biobank	We	conducted	logistic	regressions	on	email	contact	(valid	Email	address	provided	vs	no	valid	Email	address	provided)	and	MHQ	participation	(those	that	had	completed	the	MHQ	vs	those	that	had	not	completed	the	MHQ)	in	UK	Biobank,	examining	the	effects	of	age,	sex,	geographic	region,	educational	attainment,	alcohol	consumption,	smoking	status,	and	personal	and	family	history	of	disease.		We	retained	participants	with	complete	data	for	analysis	(N	=	373	478).	Odds	ratios	from	the	logistic	regressions	are	listed	in	Table	1.	Women	in	UK	Biobank	were	less	likely	to	have	provided	an	email	
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address	but	more	likely	to	take	part	in	the	MHQ.	There	was	regional	variation	in	email	contact	and	MHQ	data.	Individuals	who	attended	assessment	centres	in	Greater	London	and	the	South	West	of	England	were	the	most	likely	to	have	provided	an	email	address	while	individuals	from	assessment	centres	in	the	North	East	of	England	and	Scotland	were	the	least	likely.	Individuals	with	greater	educational	attainment,	those	who	were	not	current	smokers,	those	with	a	fewer	number	of	hospital	diagnoses,	and	those	with	a	family	history	of	dementia	or	severe	depression	were	more	likely	to	have	email	contact	and	to	have	MHQ	data.		
Table 1. Logistic regression on email contact and MHQ data in UK Biobank (N = 373  478). 
Regression coefficients are expressed as odds ratios (OR) for increased probability of having 
email contact and increased probability of having MHQ data. CI = confidence interval 
   Email contact MHQ data 
 Variable 
N OR (SE) 95% CI OR (SE) 95% CI 
 Age (SD) 373478 0.85 (0.004) 0.846-0.861 1.01 (0.004) 0.998-1.014 
Sex Female 211768 1 --- 1 --- 
 Male 161710 1.11 (0.010) 1.093-1.131 0.90 (0.008) 0.883-0.914 
Region East Midlands 25307 1 --- 1 --- 
 Greater London 50795 1.85 (0.032) 1.785-1.909 1.13 (0.022) 1.088-1.173 
 North East 27594 0.49 (0.008) 0.470-0.501 0.87 (0.018) 0.835-0.904 
 North West 54053 0.81 (0.013) 0.781-0.833 0.84 (0.012) 0.817-0.866 
 Scotland 27557 0.42 (0.009) 0.405-0.439 0.83 (0.017) 0.800-0.866 
 South East 34114 0.84 (0.016) 0.805-0.867 1.13 (0.020) 1.088-1.165 
 South West 33410 1.13 (0.021) 1.087-1.171 1.08 (0.020) 1.042-1.121 
 Wales 15741 0.58 (0.013) 0.558-0.611 0.83 (0.020) 0.796-0.873 
 West Midlands 33042 0.63 (0.011) 0.606-0.649 0.83 (0.016) 0.799-0.862 
 Yorkshire 71865 1.00 (0.016) 0.967-1.028 0.93 (0.014) 0.900-0.957 
Qualifications None 53654 1 --- 1 --- 
 GCSE 124377 2.35 (0.028) 2.297-2.408 2.29 (0.029) 2.230-2.342 
 A Levels 44132 3.43 (0.048) 3.338-3.525 3.53 (0.057) 3.421-3.642 
 Other 19583 2.53 (0.042) 2.451-2.616 2.72 (0.052) 2.620-2.823 
 College/University 131732 4.27 (0.054) 4.163-4.375 4.43 (0.056) 4.322-4.541 
Smoking Never 210858 1 --- 1 --- 
 Previous 126802 1.13 (0.009) 1.116-1.152 1.06 (0.008) 1.042-1.074 
 Current 35818 0.71 (0.009) 0.689-0.723 0.73 (0.010) 0.706-0.744 
Alcohol Units/week (SD) 373478 1.05 (0.004) 1.038-1.053 1.03 (0.005) 1.021-1.039 
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Anthropometry Body-mass index (SD) 373478 0.95 (0.004) 0.940-0.953 0.88 (0.004) 0.877-0.893 
Diagnoses Yes vs No       
 Mental disorder 
24668 0.75 (0.011) 0.729-0.774 0.68 (0.012) 0.654-0.701 
 Injury 
59706 0.90 (0.007) 0.881-0.909 0.83 (0.009) 0.815-0.851 
 Other disease 
278019 0.95 (0.009) 0.929-0.963 0.91 (0.009) 0.889-0.923 
Family history Yes 
vs No  
 
    
 Alzheimer's/dementia 52238 1.18 (0.013) 1.157-1.208 1.22 (0.013) 1.198-1.250 
 Severe depression 54651 1.04 (0.011) 1.022-1.066 1.11 (0.012) 1.084-1.131 
 		
Genome-wide	association	analysis	of	email	contact	and	MHQ	data	in	UK	Biobank	After	filtering	UK	Biobank	individuals	to	a	White	British,	unrelated	sample,	the	sample	size	was	N	=	371	417	for	the	GWAS	of	email	contact	and	N	=	371	428	for	the	GWAS	of	MHQ	data.	After	clumping,	there	were	nine	loci	(P	≤	5	×10−8)	for	email	contact	(Figure	1,	Table	2,	and	Supplementary	Table	S1)	and	25	for	MHQ	participation	(Figure	2,	Table	3,	and	Supplementary	Table	S11).	The	lGC	was	1.29	for	email	contact	and	1.37	for	MHQ	data.	The	LD	score	intercept	for	email	contact	and	MHQ	data	in	UK	Biobank	were	1.013	(SE	0.008)	and	1.020	(SE	0.008)	respectively.	This	yielded	inflation	ratios	indicating	that	only	3.7%	(SE	0.025)	and	4.3%	(SE	0.020)	of	the	inflation	in	test	statistics	for	email	contact	and	MHQ	data	were	caused	by	confounding	factors	and	thus	most	of	the	inflation	in	test	statistics	was	attributed	to	a	large	number	of	genetic	loci	influencing	both	traits	(polygenicity).				
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Table 2. Top lead SNPs associated with email contact in UK Biobank. A1= effect allele, 
Freq. = frequency of A1 allele, OR = odds ratio, S.E. = standard error. Direction of effects are 
listed for the UK Biobank discovery sample and the Generation Scotland and Partners 
Biobank replication samples as either positive (+) or negative (-). 
Chr SNP Location (Bp) A1/A2 Freq. OR (S.E.) P-value Direction 
1 rs632180 234,758,181 T/C 0.70 0.973 (0.005) 2.0 × 10-8 --+ 
2 rs7597665 34,420,702 C/T 0.29 1.031 (0.005) 1.1 × 10-9 +++ 
2 rs1455343 199,519,691 T/G 0.38 0.974 (0.005) 2.2 × 10-8 --+ 
3 rs73078357 48,695,834 C/T 0.12 1.038 (0.007) 4.5 × 10-8 +++ 
3 rs111488606 49,864,924 CA/C 0.44 0.973 (0.005) 2.3 × 10-8 --- 
5 rs6452788 87,712,913 A/G 0.24 1.032 (0.005) 2.9 × 10-9 ++- 
5 rs4976602 167,843,998 A/G 0.11 0.96 (0.007) 2.7 × 10-8 --- 
6 rs1487441 98,553,894 A/G 0.49 1.031 (0.005) 9.5 × 10-12 +++ 
18 rs1788784 21,159,630 G/A 0.66 1.031 (0.005) 1.3 × 10-10 +++ 
 
 
Figure 1. Manhattan plot of email contact in UK Biobank.  
 
	
Table 3. Top lead SNPs associated with MHQ data. A1= effect allele, Freq. = frequency of 
A1 allele, OR = odds ratio, S.E. = standard error. Direction of effects are listed for the UK 
Biobank discovery sample and the Generation Scotland and Partners Biobank replication 
samples as either positive (+) or negative (-). 
Chr SNP Location (Bp) A1/A2 Freq. OR (S.E.) P-value Direction 
1 rs7542974 72,544,704 A/G 0.25 1.032 (0.006) 3.8 × 10-8 +++ 
1 rs485929 74,678,285 G/A 0.39 1.028 (0.005) 3.7 × 10-8 +-+ 
1 rs532246 84,411,238 G/A 0.74 0.968 (0.005) 7.0 × 10-9 -+- 
1 rs2789111 243,346,404 C/T 0.38 0.968 (0.005) 1.5 × 10-10 --+ 
2 rs35028061 49,479,987 GT/G 0.38 1.029 (0.005) 1.9 × 10-8 +-- 
3 rs9917656 48,581,513 C/T 0.30 1.03 (0.006) 3.2 × 10-8 ++- 
3 rs13082026 52,962,681 T/C 0.44 0.972 (0.005) 2.4 × 10-8 --+ 
4 rs57692580 106,214,476 A/T 0.39 0.973 (0.005) 2.8 × 10-8 -++ 
5 rs34635 60,513,501 G/A 0.42 0.972 (0.005) 1.2 × 10-8 --- 
5 rs146681214 133,867,867 AC/A 0.18 1.039 (0.007) 3.6 × 10-9 +++ 
5 rs2336897 167,050,276 T/C 0.69 1.031 (0.005) 5.2 × 10-9 ++- 
6 rs3993747 31,580,507 G/A 0.35 0.969 (0.005) 9.5 × 10-10 --- 
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6 rs59732267 98,432,302 CA/C 0.52 0.972 (0.005) 2.5 × 10-8 --- 
8 rs28716319 83,269,854 G/A 0.28 1.031 (0.005) 2.7 × 10-8 +-+ 
8 rs13262595 143,316,970 G/A 0.56 1.03 (0.005) 1.0 × 10-9 +++ 
9 rs6474966 15,757,537 A/G 0.46 1.028 (0.005) 2.8 × 10-8 +++ 
9 rs11793831 23,362,311 T/G 0.42 1.027 (0.005) 4.3 × 10-8 +-+ 
11 rs1984389 31,740,989 C/A 0.54 0.973 (0.005) 2.4 × 10-8 --- 
11 rs10791143 131,278,676 G/A 0.62 1.034 (0.005) 1.5 × 10-11 +++ 
16 rs4616299 7,657,432 G/A 0.40 0.972 (0.005) 1.2 × 10-8 --- 
17 rs56058331 56,427,128 A/G 0.42 1.029 (0.005) 1.0 × 10-8 +++ 
18 rs1261078 52,866,791 G/A 0.05 0.927 (0.010) 5.6 × 10-12 -+- 
19 rs34232444 4,965,404 C/T 0.35 1.029 (0.005) 2.5 × 10-8 ++- 
19 rs3746187 18,279,816 G/A 0.40 0.968 (0.005) 9.8 × 10-11 --- 
19 rs429358 45,411,941 C/T 0.15 0.942 (0.006) 4.6 × 10-19 --- 
 	
Figure	2.	Manhattan	plot	of	data	available	in	MHQ	follow-up	
		
Loci	discovery	and	annotation	of	the	Email	contact	and	MHQ	phenotypes	The	nine	loci	associated	with	email	contact	were	found	to	contain	an	overrepresentation	of	SNPs	found	in	ncRNA	intronic	regions	(57.5%),	as	well	as	SNPs	found	in	intronic	regions	(28.4%)	(Supplementary	Figure	S1	and	Supplementary	Table	S1).	Evidence	was	also	found	that	these	loci	contained	regulatory	regions	of	the	genome,	indicated	by	32.0%	of	the	SNPs	in	the	genomic	loci	having	RegulomeDB	(RDB)	less	than	2,	indicating	that	genetic	variation	in	these	loci	is	likely	to	affect	gene	expression.	Finally,	77.6%	of	the	SNPs	within	the	independent	genomic	loci	had	a	minimum	
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chromatin	state	of	<	8.	This	is	further	evidence	that	these	loci	are	located	in	an	open	chromatin	state	and	that	they	are	located	within	regulatory	regions.	Using	the	GWAS	catalogue,	lead	and	tagging	SNPs	from	these	9	independent	genomic	loci	were	found	to	overlap	with	loci	previously	associated	with	body	mass	index	and	obesity	(2	loci),	as	well	as	with	educational	attainment	and	intelligence	(3	loci).	(Supplementary	Table	S2).	The	25	loci	associated	with	the	MHQ	participation	phenotype	notably	included	rs429358,	a	missense	mutation	in	APOE.	The	rs429358-C	allele	is	a	marker	for	APOE-	ε4	genotype,	and	the	direction	of	the	effect	for	this	SNP	indicated	that	participants	with	more	copies	of	APOE-ε4	were	less	likely	to	participate	in	the	MHQ	(OR	=	0.942±0.0057SE	for	each	additional	ε4	copy).	Functional	annotation	of	the	SNPs	found	within	these	regions	showed	that	these	SNPs	were	primarily	located	in	introns	(47.3%),	and	intergenic	regions	(17.7%)	and	2.9%	had	no	known	function	(Supplementary	Figure	S2	and	Supplementary	Table	S8).	Of	these	SNPs,	30.8%	had	an	RDB	score	of	less	than	2	and	83.8%	had	a	minimum	chromatin	value	of	less	than	8	providing	further	evidence	that	these	variants	are	located	in	regions	of	the	genome	that	are	linked	to	gene	regulation.	These	25	loci	showed	overlap	with	the	loci	identified	in	previous	GWAS	examining	cognitive	abilities	and	education	(6	loci),	Schizophrenia	(5	loci),	and	Alzheimer’s	Disease	(1	locus)	(Supplementary	Table	S9).		
	
Gene	mapping	of	the	Email	access	and	MHQ	phenotype	We	used	three	strategies	for	mapping	the	SNPs	in	the	associated	loci	to	genes.	First,	positional	mapping	aligned	the	SNPs	from	the	independent	genomic	loci	associated	with	email	contact	to	20	genes	by	using	location,	whereas	eQTL	mapping	matched	cis-eQTL	SNPs	to	40	genes	whose	level	of	expression	they	have	been	shown	to	influence.	Finally,	chromatin	interaction	mapping	annotated	SNPs	to	a	total	of	41	genes,	
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using	three-dimensional	DNA-DNA	interactions	between	the	SNPs’	genomic	regions,	and	close	or	distant	genes	(Supplementary	Tables	S4	and	S5,	Supplementary	Figure	5a–f).	Collectively	these	mapping	strategies	identified	70	unique	genes,	of	which	21	were	implicated	by	two	mapping	strategies	and	10	being	implicated	by	all	three.	A	total	of	five	genes,	TNNI3K,	LRRIQ3,	NEGR1,	FPGT,	and	FPGT-TNNI3K,	were	implicated	using	all	three	methods	and	showed	evidence	of	a	chromatin	interaction	between	two	independent	genomic	risk	loci	(Supplementary	Table	S4).	Gene-based	statistics	derived	in	MAGMA	indicated	a	role	for	72	genes	(Supplementary	Table	S5),	4	of	which	overlapped	with	genes	implicated	by	all	three	mapping	strategies	(Supplementary	Figure	S3).	For	the	MHQ	data	phenotype,	positional	mapping	implicated	42	genes,	with	eQTL	mapping	indicating	a	role	for	86	genes.	Chromatin	interaction	mapping	annotated	a	total	of	124	genes	(Supplementary	Tables	S14	and	S15,	Supplementary	Figure	S6a-m).	Across	these	three	mapping	strategies,	181	unique	genes	were	identified	with	46	of	these	being	implicated	by	two	mapping	strategies	and	25	being	implicated	by	all	three	MAGMA	was	also	used	and	indicated	a	role	for	81	genes	(Supplementary	Figure	S4	and	Supplementary	Table	S15).	Fifteen	of	these	81	genes	overlapped	with	those	identified	using	the	three	mapping	strategies.		
Gene-set	and	gene	property	analysis	The	presynaptic	membrane	gene-set	was	enriched	for	the	Email	contact	phenotype	(P	=	5.19×10−7)	(Supplementary	Table	S6).	Gene	property	analysis	showed	a	relationship	between	expression	in	the	EBV-transformed	lymphocyte	cells	(P	=	9.24×10−4)	and	for	gene	expression	in	the	early	mid-prenatal	time	of	life	(P	=	0.004)	(Supplementary	Tables	S9	and	S10).	
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	For	the	MHQ	data	phenotype	none	of	the	gene	sets	were	enriched	(Supplementary	Table	S16).	However,	gene	property	analysis	indicated	a	relationship	between	gene	expression	in	the	brain	and	the	MHQ	phenotype	(P	=	2.64×10−4)	(Supplementary	Table	S17)	when	examining	the	specific	tissue	gene	groupings	this	relationship	was	driven	by	expression	change	in	the	cerebellar	hemisphere	(P	=	8.52×10−6)	and	the	Cerebellum	(P	=	1.27×10−5)	(Supplementary	Table	S18).	A	relationship	between	gene	expression	in	the	early	prenatal	lifespan	range	(P	=	0.002)	and	the	early	mid-prenatal	lifespan	was	also	found	(P	=	5.33×10−4)	(Supplementary	Table	S19).	
	
LD	Score	regression	analysis	We	used	LD	score	regression	to	estimate	SNP	heritability	from	the	GWAS	results.	Heritability	on	the	liability	scale	for	email	contact	was	0.073	(0.004SE)	and	for	MHQ	data	was	0.099	(0.004SE).	The	genetic	correlation	between	email	contact	and	MHQ	data	was	0.822	(0.020SE).			We	used	LD	Hub	19	to	estimate	genetic	correlations	with	a	large	number	of	other	traits.	Both	email	contact	and	having	MHQ	data	were	genetically	correlated	with	a	broad	spectrum	of	traits.	Results	for	an	illustrative	set	of	traits	is	plotted	in	Figure	3	and	the	results	for	all	traits	are	listed	in	Supplementary	Table	S21.	For	most	anthropometric,	behavioral,	cognitive,	psychiatric,	health-related,	and	life-history	traits	the	direction	of	the	genetic	correlations	with	email	contact	and	MHQ	participation	was	the	same.	In	general,	genetic	factors	associated	with	providing	an	email	address	for	recontact	to	UK	Biobank	and	taking	part	in	the	MHQ	were	also	associated	with	better	health,	higher	intelligence,	lower	burden	of	psychiatric	disorders,	and	a	slower	life-history	(e.g.,	later	
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age	at	menarche,	age	at	first	birth,	and	age	at	menopause).	Both	email	contact	and	MHQ	participation	were	not	genetically	correlated	with	any	traits	categorized	as	bone,	kidney,	uric	acid,	and	metals	(transferrin/ferritin).	Additionally,	email	contact	was	not	genetically	correlated	with	glycemic	traits	while	MHQ	data	availability	was	not	genetically	correlated	with	hormone	or	metabolite	phenotypes.		
Figure	3.	LD	Score	genetic	correlations	(rg)	with	email	contact	(triangle)	and	MHQ	data	(circle),	with	95%	confidence	intervals.		
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Effect	of	mortality	on	MHQ	genetic	associations	To	test	for	the	roll	of	mortality	on	our	findings,	we	re-ran	the	genome-wide	association	analysis	of	MHQ	data	availability	after	removing	participants	whose	dates	of	death	occurred	before	the	MHQ	assessment.	The	overall	inflation	in	association	test	statistics	including	and	excluding	deceased	participants	was	identical	(mean	χ2	=	1.438)	and	the	genetic	correlation	between	the	two	sets	of	summary	statistics	was	0.9996	(SE	=	0.0002).	We	compared	the	top	independent	associated	SNPs	in	the	GWAS	in	the	larger	sample	to	those	that	excluded	deaths	(Supplementary	Table	S24	and	Figure	S7).	While	there	three	SNPs	that	no	longer	passed	the	criterion	for	genome-wide	significance,	there	was	no	appreciable	change	in	the	effect	sizes	estimates	for	any	of	the	SNPs	.	
Replication	in	Generation	Scotland	and	Partners	Biobank		 We	examined	whether	any	of	the	associations	results	for	the	email	and	MHQ	data	phenotypes	replicated	in	an	independent	sample,	using	whether	members	of	Generation	Scotland	participated	in	the	STRADL	follow-up	of	mental	health.	At	an	alpha	criterion	of	0.05/34	and	an	average	genotype	relative	risk	of	1.015,	there	was	4%	power	to	replicate	in	Generation	Scotland	and	2%	power	in	Partners	Biobank,	and	replicating	the	UK	Biobank	findings	requires	approximately	200,000	cases	and	controls	to	achieve	90%	power.18			None	of	the	independent	SNPs	in	the	UKB	GWASs	replicated	in	Generation	Scotland	after	Bonferroni	correction	(34	tests)	(Supplementary	Tables	S22	and	S23).		We	observed	replication	evidence	for	one	independent	SNP	(rs9917656,	6.2	×	10-4)	in	Partners	Biobank	after	Bonferroni	correction	(Supplementary	Tables	S22	and	S23).	Between	UK	Biobank	and	Partners	Biobank,	more	of	the	SNPs	for	survey	participation	had	the	same	direction	of	effect	than	expected	(20/25,	exact	binomial	test	
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p-value	=	0.002).	Furthermore,	the	STRADL	data	phenotype	was	moderately	genetically	correlated	with	both	UKB	email	contact	(rg	=	0.430,	SE	=	0.112,	p	=	0.0001)	and	UKB	MHQ	data	(rg	=	0.619,	SE	=	0.130,	p	=	1.98	×	10-6)	and	had	a	SNP	heritability	on	the	liability	scale	of	0.112	(SE	0.0408).	 	
	
Discussion	
Using	data	from	UK	Biobank,	we	found	that	individuals	who	provided	an	email	address	for	recontact	and	who	participated	in	follow-up	surveys	of	mental	health	differed	from	those	who	did	not	with	regards	to	demographic,	psychological,	health,	and	lifestyle,	and	genetic	factors.	The	UK	Biobank	sample	differs	from	the	UK	population	20,	and	our	results	show	that	ascertainment	processes	also	exert	an	effect	on	follow	up	assessments.	Most	of	the	phenotypic	and	genetic	associations	were	in	the	same	direction.	These	results	were	not	due	to	population	stratification	as	only	4%	of	the	inflation	in	GWAS	statistics	could	be	attributed	to	factors	other	than	polygenic	heritability.	Having	greater	educational	attainment,	being	a	non-smoker	or	a	former	smoker,	having	fewer	hospital	diagnoses	of	illness	or	injury,	and	having	a	family	history	of	dementia	or	a	family	history	of	serious	depression	all	predicted	greater	likelihood	of	providing	email	contact	information.	Furthermore,	those	variables	were	also	associated	with	providing	responses	to	the	online	Mental	Health	Questionnaire	(MHQ).	Importantly	for	understanding	the	composition	of	the	MHQ	subset,	having	an	inpatient	diagnoses	of	a	mental	disorder	was	associated	with	lower	participation	rates	in	the	MHQ	(OR	=	0.68,	95%	CI	=	0.65-0.70),	and	this	was	a	larger	effect	size	than	other	hospital	diagnoses,	specifically	injury	(OR	=	0.83)	and	non-psychiatric	disorders	(OR	=	
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0.91).	A	few	effects	went	in	the	opposite	direction	between	the	email	contact	and	MHQ	data	variables,	with	men	and	younger	individuals	more	likely	to	provide	an	email	address	to	UK	Biobank,	whereas	women	were	more	likely	to	provide	MHQ	data.		 Email	contact	and	MHQ	data	availability	had	SNP	heritabilities	of	7.3%	and	9.9%	respectively.	We	identified	nine	independent	SNPs	associated	with	email	contact	and	25	for	MHQ	data,	more	than	for	many	GWAS	studies	of	disease	traits	in	the	same	sample.	Loci	for	both	phenotypes	were	mostly	located	within	regulatory	regions.	Of	particular	interest	was	the	association	of	apolipoprotein	E	(APOE)	ε4	genotype,	which	is	a	major	risk	factor	for	Alzheimer's	disease	21,	with	a	decrease	in	participation	in	the	MHQ	follow-up.		One	SNP	associated	with	MHQ	data	replicated	in	the	Partners	Biobank	sample.	The	SNP,	rs9917656,	in	an	intron	in	the	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase	4	(PFKFB4),	a	signally	enzyme	involved	in	switching	between	different	forms	of	carbohydrate	metabolism.22.	However,	several	other	genes	are	implicated	in	this	locus	by	positional	mapping	(genomic	locus	6	in	Supplementary	Table	S13).	Given	the	effect	sizes	found	in	the	discovery	sample,	both	Generation	Scotland	and	Partners	were	underpowered	for	replicating	association	results.	However,	the	consistent	directions	of	effect	in	the	Partners	cohort	and	the	strong	genetic	correlation	between	STRADL	participation	and	the	email	contact	and	MHQ	data	phenotypes	suggests	that	similar	genetic	factors	are	driving	participation	in	follow-up	studies.		 Email	contact	and	MHQ	data	shared	similar	genetic	correlations	with	other	traits.	There	were	strong	genetic	correlations	between	email	contact	and	indicators	of	cognitive	ability	(college	completion,	rg	=	0.76;	intelligence,	rg	=	0.73).	Contact	and	data	availability	were	also	genetically	associated	with	a	lower	burden	of	genetic	risk	to	mental	illness	and	lower	BMI.	These	results	were	in	the	same	direction	as	the	phenotypic	analysis.	The	negative	genetic	correlation	with	schizophrenia	matches	
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results	from	follow-up	participation	in	the	ALSPAC	cohort	using	polygenic	risk	scores	6	and	suggests	that	this	association	is	not	specific	to	schizophrenia.		 The	similarity	in	the	results	for	phenotypic	and	genetic	factors	associated	with	email	contact	and	MHQ	data	show	that	the	availability	of	an	individual	to	be	contacted	by	email	and	their	choice	to	participate	both	act	as	a	filter	for	selection	into	the	subsample	of	UK	Biobank	with	Mental	Health	Questionnaire	data.	Notably,	self-reports	of	a	family	history	of	dementia	and	a	family	history	of	severe	depression	were	more	common	in	email	providers	and	MHQ	completers,	but	individual	genetic	associations	with	both	these	disorders	showed	negative	correlations.	Individuals	who	reported	dementia	or	severe	depression	in	their	family	were	therefore	more	likely	to	be	MHQ	participants,	even	though	having	a	personal	genetic	predisposition	to	these	disorders	may	also	decrease	their	likelihood	of	participating.	Knowledge	of	family	history	may	be	a	strong	motivational	factor	for	participating	in	follow-up	surveys	of	mental	health.			 Our	sample	was	large	enough	that	we	were	able	to	identify	specific	genetic	loci	that	were	related	to	participation	in	follow	up	studies	of	mental	health.	We	were	also	able	to	analyse	the	genetics	of	one	particular	factor	(the	availability	of	email	contact	for	receiving	invitations)	that	is	heavily	involved	in	the	specific	process	of	follow-up	participation.	However,	a	limitation	of	our	analysis	is	that	information	on	email	contact	was	available	for	participants	at	baseline	only	and	thus	did	not	distinguish	the	entire	subset	of	participants	who	would	have	received	an	email	invitation.	Another	limitation	is	that	information	from	electronic	health	records	only	covered	hospital	admissions	and	thus	would	underestimate	associations	with	milder	health	conditions.	Our	study	also	does	not	address	factors	that	would	differentially	influence	participation	of	individuals	of	non-European	ancestry.			
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Figure 4. Possible effects of selection bias on polygenic risk score analyses in follow-up 
studies. PRS = Polygenic Risk Score, X and Y = phenotypes of interest, F = selection into 
follow-up, directional solid line = true causal association, dashed line = induced or attenuated 
statistical dependence. A. Causal model to be tested where PRS causes phenotype Y via 
phenotype X B. Worst-case scenario where PRS influences X but not Y and both phenotypes 
cause follow-up participation. Analysing only follow-up participants is the same as 
conditioning on F, which induces a correlation between PRS and Y. C. More likely scenario, 
where both X and Y cause follow-up participation. Conditioning on F attenuates estimates of 
the relationship between PRS and Y. D. Ideal scenario where X causes follow-up 
participation, but Y does not. Conditioning on F has no impact on the dependence of Y on 
PRS.  
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	 Individuals	in	large	epidemiological	cohorts	who	participate	in	follow-up	surveys	differ	in	their	patterns	of	phenotypic	and	genetic	association	with	traits	of	interest	from	those	who	do	not.	Because	most	factors	had	a	consistent	relationship	with	the	two-step	selection	process	(contactability	by	email	and	opting	to	participate	in	follow-up),	it	is	likely	that	these	same	factors	may	also	differentiate	people	who	choose	to	become	part	of	the	cohort	in	the	first	place	from	other	people	in	the	larger	population.	These	factors	are	very	likely	to	bias	the	selection	of	individuals	selected	for	inclusion	in	population-based	studies	towards	those	with	positive	family	histories	but	lower	personal	genetic	risk	of	mental	health	conditions	such	as	depression	and	dementia.	Analysing	variables	within	a	follow-up	study	may	have	the	effect	inducing	statistical	dependence	or	attenuating	estimates	of	the	relationships	among	variables	2.	Figure	4a	illustrates	a	hypothesised	causal	model	where	a	polygenic	risk	score	(PRS)	influences	a	phenotype	or	outcome	Y	via	an	intermediate	phenotype	X.	This	model	could	be	tested	by	d-separation23:	if	the	model	is	true,	then	regressing	Y	on	X	will	result	in	conditional	independence	of	PRS	and	Y.	Figure	4b	illustrates	a	scenario	analysing	the	effect	of	the	PRS	where	participation	in	follow-up	is	a	collider	for	the	two	phenotypes	when	they	do	not	have	a	causal	relationship	with	each	other.	Analysing	data	only	within	the	follow-up	sample	creates	non-independence	between	the	X	and	Y	traits	and	thus	between	PRS	and	
Y.	Even	when	one	trait	causes	the	other,	conditioning	on	follow-up	participation	can	bias	the	estimate	of	PRS	on	the	downstream	trait	(Figure	4c).	A	scenario	where	only	one	of	the	traits	causes	follow-up	would	not	result	in	biased	estimates	of	the	effects	of	PRS	(Figure	4d).	Going	forward,	studies	should	evaluate	(e.g.,	using	simulations	2)	the	particular	effects	that	selection	and	attrition	might	have	on	effect	estimates	and,	where	available,	check	results	from	follow-up	assessments	against	those	from	baseline	data,	even	in	the	
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cases	where	the	follow-up	data	provides	better	or	more	comprehensive	measures	of	phenotypes	of	interest.		Because	continued	participation	in	large	cohorts	studies	recapitulates	the	“healthy	volunteer”	effect,	comparing	responders	and	non-responders	in	follow-up	surveys	may	be	a	useful	way	to	analyse	how	selection	bias	may	influence	the	generalizability	and	accuracy	of	findings.			
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Logistic	regression	analysis	input	coding	
We	centered	and	standardized	age.	We	determined	geographic	region	by	grouping	the	assessment	centres	together	into	regions	of	England	(South	East,	South	West,	East	Midlands,	West	Midlands,	North	West,	North	East,	and	Yorkshire),	Greater	London,	Scotland,	and	Wales.	Education,	smoking,	drinking,	and	family	history	were	assessed	by	means	of	a	touchscreen	interview	during	the	initial	assessment.	We	categorized	educational	qualifications	as	None,	Professional,	Higher	(college	or	university),	Secondary	(A	levels,	O	levels,	GCSEs,	CSEs),	and	Vocational	(NVQ,	HND,	HNC).	Smoking	history	had	the	responses	'Prefer	not	to	answer',	'Never',	'Previous',	and	'Current'.	For	alcohol	drinking,	participants	reported	their	average	weekly	and	monthly	consumption	for	different	drink	types	from	which	we	derived	a	measure	of	average	alcohol	consumption	in	units	per	week	(Clarke	et	al.,	2017)	and	standardized	this	variable	for	input	into	the	model.	For	linked	hospital	records,	we	first	removed	diagnoses	related	to	pregnancy	(ICD-10	chapter	O),	congenital	conditions	(chapter	Q),	and	health	care	provision	(chapters	U	and	Z).	For	the	remaining	diagnoses,	we	categorized	them	into	mental	health	conditions	and	addictions	(chapter	F),	injuries	(chapter	S,	T,	V,	and	Y),	and	all	other	diseases.	Participants	were	assigned	a	value	of	1	for	each	category	if	they	had	any	diagnostic	codes	in	that	category.	Participants	with	linked	hospital	records	who	did	not	have	any	incidences	of	a	diagnostic	category	were	assigned	a	count	of	0.	
Genotyping,	genomic	QC,	and	GWAS	
UK	Biobank	contains	genotype	data	imputed	to	~92	million	variants	(Bycroft	et	al.,	2018).	We	performed	QC	procedures	on	SNPs	with	filters	for	MAF	>	0.001	and	INFO	>	0.1.	We	removed	participants	who	had	failed	genotype	platform	QC,	who	did	not	cluster	genetically	as	White	British,	or	who	overlapped	with	Psychiatric	Genomics	Consortium	MDD	and	Generation	Scotland	participants;	and	we	conducted	additional	filtering	on	related	individuals	(Howard	et	al.,	2018).	This	resulted	in	16	367	095	variants	for	371	428	individuals	for	genetic	analysis	(Supplementary	Figure	S8).	We	conducted	genome-wide	association	analyses	using	BGENIE	v1.3	(Bycroft	et	al.,	2018)	that	coded	the	outcome	variables	as	0/1	in	a	linear	regression.	We	covaried	for	age,	sex,	assessment	centre,	genotyping	platform,	and	20	UKB-provided	principal	components.	We	approximated	odds	ratios	for	the	SNP	effects	using	the	transformation	to	the	log-odds	scale,	log(OR) = "	 (%	(1	 − 	%))⁄ ,	where	k	is	the	fraction	of	participants	who	were	coded	as	1	in	the	outcomes	variable	(email	contact	k	=	0.6,	MHQ	data	k	=	0.33).	
	 For	Generation	Scotland,	8	642	105	imputed	variants	were	available	for	19	994	participants	(Hall	et	al.,	2018).	Variants	with	MAF	<	0.005	and	INFO	<	0.8	were	excluded.	We	performed	association	tests	on	the	STRADL	data	phenotype	using	the	mixed	linear	model	with	candidate	marker	excluded	(MLMe)	approach	in	GCTA	v1.91.1	(Yang,	Zaitlen,	Goddard,	Visscher,	&	Price,	2014).	We	constructed	two	GRMs	using	a	leave-one-chromosome-out	(LOCO)	approach:	one	GRM	that	included	all	relationship	coefficients	and	a	second	GRM	that	set	relatedness	to	0	when	the	relationship	coefficients	<	0.025	(Zaitlen	et	al.,	2013).	We	fitted	age	and	sex	as	covariates.	To	see	if	the	results	from	the	UKB	phenotypes	replicated,	we	looked	up	each	independent	significant	SNP	(or	an	LD	proxy)	in	the	GWAS	of	the	STRADL	data	phenotype	and	assessed	whether	they	were	significant	after	Bonferroni	correction.	We	also	calculated	the	LD	score	genetic	correlation	of	the	STRADL	data	phenotype	with	the	UKB	email	and	MHQ	data	phenotypes.		
	 For	Partners	Biobank,	DNA	from	participants	was	genotyped	using	~1.6	million	SNPs	on	the	Illumina	Multi-Ethnic	GWAS/Exome	SNP	Array	and	imputed	using	Minimac3	using	the	HRC	(Version	r1.1	2016)	reference	panel	(Dashti,	Redline,	&	Saxena,	2018).	Replication	was	sought	for	the	35	identified	signals	(or	an	LD	proxy).	Individual	SNPs	association	analyses	were	conducted	using	logistic	regression	analyses	and	an	additive	genetic	model	in	PLINK	adjusted	for	age,	sex,	genotyping	array,	and	principal	components	of	ancestry.	Associations	were	considered	significant	after	Bonferroni	correction.		
Loci	discovery	and	functional	annotation	
Genomic	risk	loci	were	derived	using	clumping,	carried	out	in	FUnctional	Mapping	and	Annotation	of	genetic	associations	(FUMA)	(Watanabe,	Taskesen,	van	Bochoven,	&	Posthuma,	2017).	First,	FUMA	was	used	to	identify	independent	significant	SNPs	using	the	SNP2GENE	function.	SNPs	with	a	P-value	of	≤	5	×10−8	and	independent	of	other	genome	wide	significant	SNPs	at	r2	<	0.6	were	identified	from	the	summary	GWAS	statistics	of	the	UKB	email	contact	and	MHQ	data	phenotypes.	Second,	using	these	independent	significant	SNPs,	candidate	SNPs	were	identified	as	all	SNPs	that	had	a	MAF	>	0.001	and	were	in	LD	of	≥	r2	0.6	with	at	least	one	of	the	independent	significant	SNPs.	These	candidate	SNPs	included	those	from	the	UK10K/1000G	and	the	haplotype	reference	consortia	panel	(UK	Biobank	release	1)	and	may	not	have	been	included	in	the	UKB	GWASs.	Third,	lead	SNPs	were	identified	using	the	independent	significant	SNPs.	Lead	SNPs	were	defined	as	SNPs	that	were	independent	from	each	other	at	r2	0.1.	Finally,	genomic	risk	loci	that	were	250kb	or	closer	were	merged	to	form	a	single	locus.		
The	lead	SNPs	identified	above,	and	those	in	LD	with	the	lead	SNPs,	were	then	mapped	to	genes	using	ANNOVAR	and	the	Ensemble	genes	build	85.	Intergenic	SNPs	were	mapped	to	the	two	closest	up-	and	downstream	genes	which	can	result	in	them	being	assigned	to	multiple	genes.		eQTL	mapping	was	performed	using	each	independent	significant	SNP	and	those	in	LD	with	it.	Those	SNP-gene	pairs	that	were	not	significant	(FDR	≤	0.05)	were	omitted	from	the	analysis.	
Gene-mapping	
Genetic	variation	in	each	of	the	independent	genomic	loci	was	mapped	to	genes	using	three	complementary	strategies.	First,	positional	mapping	was	used	to	map	SNPs	to	genes	based	on	physical	distance.	SNPs	within	a	10kb	window	from	the	known	protein	genes	found	in	the	human	reference	assembly	(hg19).	Second,	expression	quantitative	trait	loci	(eQTL)	mapping	was	carried	out	by	mapping	SNPs	to	genes	if	allelic	variation	at	the	SNP	was	associated	with	expression	levels	of	the	gene.	For	eQTL	mapping	information	on	45	tissue	types	from	three	data	bases	(GTEx,	Blood	eQTL	browser,	BIOS	QTL	browser)	based	on	cis-QTLs	where	a	SNPs	are	mapped	to	genes	up	to	1Mb	away.	A	false	discovery	rate	(FDR)	of	0.05	was	used	as	a	cut	off	to	define	significant	eQTL	associations.	
Finally,	chromatin	interaction	mapping	was	carried	out	to	map	SNPs	to	genes	when	there	is	a	three-dimensional	DNA-DNA	interaction	between	the	independent	genomic	risk	loci	with	a	gene	region.	Chromatin	interactions	can	involve	long-range	interactions	between	SNPs	with	genes	as	such	no	genomic	distance	boundary	is	applied.	Hi-C	data	of	14	tissue	types	was	used	for	chromatin	interaction	mapping.	Chromatin	interactions	can	also	span	multiple	genes,	and	SNPs	can	be	located	in	a	region	that	interacts	with	other	regions	also	containing	multiple	genes.	In	order	to	both	reduce	the	number	of	genes	mapped,	and	to	increase	the	probability	that	those	genes	mapped	are	biologically	linked	to	genetic	variation	at	the	independent	genomic	loci,	only	genes	where	one	region	involved	with	the	interaction	overlapped	with	a	predicted	enhancer	region	in	any	of	the	111	tissue/cell	types	found	in	the	Roadmap	Epigenomics	Project	(Bernstein	et	al.,	2010),	and	the	other	region	was	located	in	a	gene	promoter	region	(250bp	upstream	and	500bp	downstream	of	the	transcription	start	site	and	also	predicted	to	be	a	promoter	region	by	the	Roadmap	Epigenomics	Project)	were	included	here.	An	FDR	of	1×10−5	was	used	to	define	a	significant	interaction.	
Gene-based	GWAS	
Gene-based	analyses	have	been	shown	to	increase	the	power	to	detect	association	due	to	the	multiple	testing	burden	being	reduced,	in	addition	to	the	effect	of	multiple	SNPs	being	combined.	Gene-based	GWAS	was	conducted	using	MAGMA	(de	Leeuw,	Mooij,	Heskes,	&	Posthuma,	2015),	also	implemented	in	FUMA	(Watanabe	et	al.,	2017).	Regardless	of	P-value,	all	SNPs	located	within	protein	coding	genes	were	used	to	derive	a	P-value	describing	the	association	between	genetic	variation	across	the	gene	with	either	email	or	questionnaire.	The	NCBI	build	37	was	used	to	determine	the	location	and	boundaries	of	18	877	autosomal	genes	and	linkage	disequilibrium	within	and	between	genes	was	gauged	using	the	UK	Biobank	1	reference	panel.	A	Bonferroni	correction	was	applied	to	control	for	the	number	of	genes	tested.			
	
Gene-set	analysis	
A	competitive	gene-set	analysis	was	conducted	in	MAGMA	to	identify	the	biological	systems	vulnerable	to	perturbation	by	common	genetic	variation.	Competitive	testing	examines	if	genes	within	the	gene	set	are	more	strongly	associated	with	the	trait	of	interest	than	genes	from	outside	the	gene	set,	and	differs	from	self-contained	testing	by	controlling	for	type	1	error	rate	as	well	as	being	able	examine	the	biological	relevance	of	the	gene-set	under	investigation.	
A	total	of	10	894	gene-sets	(sourced	from	Gene	Ontology,	Reactome,	and,	MSigDB)	were	examined	for	enrichment.	To	control	for	the	10,894	gene	sets	examined,	a	Bonferroni	correction	was	applied.	
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Figure S1. Functional categories, RDB scores, and minimum chromatin states for independent risk loci associated with UKB email contact. 
 
 
Figure S2. Functional categories, RDB scores, and minimum chromatin states for independent risk loci associated with UKB MHQ participation. 
  
Figure S3. Number of genes implicated by different mapping strategies for UKB email contact. 
Figure S4. Number of genes implicated by different mapping strategies for UKB MHQ data.  
 
 
 
Supplementary Figures S5 and S6.  
 
Circos plots by chromosome illustrating genome-wide significant loci associated with the 
Email contact and the MHQ data phenotype are shown. For each phenotype the most outer 
layer shows the Manhattan plot and only SNPs where P <0.05 are shown. Each of the SNPs 
in the genomic risk loci are colour coded indicating the maximum r2 with one of the 
independent significant SNPs in the locus with red indicating the highest r2 and blue the 
lowest r2(red r2>0.8, orange r2>0.6, green r2>0.4, and blue r2>0.2). SNPs shown in grey are 
not in LD with any of the genome wide significant SNPs. The rsID of the most significant lead 
SNP in each loci is shown. The second layer is the chromosomal ring with the independent 
genomic risk loci highlighted in blue. Next, the genes mapped by chromatin interactions or 
eQTLs are displayed. Genes mapped using chromatin interactions the gene is displayed in 
orange, with genes mapped by eQTL shown in green. Genes that are displayed in red are 
those mapped using both chromatin interactions and eQTLs. Chromatin interaction links 
(coloured orange for chromatin interactions and green for eQTLs are displayed. 
 
 
 
 
 
 
Figure S5a. Circos plot for email contact chromosome 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5b. Circos plot for email contact chromosome 2 
 
 
 
Figure S5c. Circos plot for email contact chromosome 3 
 
 
Figure S5d. Circos plot for email contact chromosome 5 
 
 
Figure S5e. Circos plot for email contact chromosome 6 
 
 
 
Figure S5f. Circos plot for email contact chromosome 18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6a. Circos plot for MHQ data chromosome 1 
 
 
Figure S6b. Circos plot for MHQ data chromosome 2 
 
 
 
Figure S6c. Circos plot for MHQ data chromosome 3 
 
Figure S6d. Circos plot for MHQ data chromosome 4 
 
 
 
 
Figure S6e. Circos plot for MHQ data chromosome 5 
 
Figure S6f. Circos plot for MHQ data chromosome 6 
 
 
 
 
Figure S6g. Circos plot for MHQ data chromosome 8 
 
Figure S6h. Circos plot for MHQ data chromosome 9 
 
 
 
 
Figure S6i. Circos plot for MHQ data chromosome 11 
 
Figure S6j. Circos plot for MHQ data chromosome 16 
 
 
 
 
Figure S6k. Circos plot for MHQ data chromosome 17 
 
Figure S6l. Circos plot for MHQ data chromosome 18 
 
 
 
 
Figure S6m. Circos plot for MHQ data chromosome 19 
 
 
 
 
 
  
Figure S7. Comparison of effect sizes (as odds ratios) from top independent SNPs in the 
MHQ GWAS (x axis) compared to the MHQ GWAS whose deaths were reported before the 
recontact assessment period (y axis). Each SNP is plotted as overlaid with two sets of 
confidence intervals bars: 95% confidence interval (green) for assessing whether the effect 
size differs between the two GWAS; 99.999995% confidence interval (orange) for assessing 
whether the effect size differs from 1.0. 
  
Figure S8. Filtering of the UK Biobank sample for genetic analysis. White British ancestry was 
determined by four-mean clustering of genetic principal components. Study overlap used 
genotype checksums to check for overlap with Psychiatric Genomics Consortium Major 
Depressive Disorder and Generation Scotland cohorts.  
 
 
